Events

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

2:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-918761

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

12:00 PM EDT

RACE# 27059-1119546

1.5 RACE-Approved Credit Hour 
 

This lecture will discuss the importance of topical therapy in the management of canine atopic dermatitis. We will review the changes detected in the skin of affected animals with a focus on the epidermal barrier. We will discuss the importance of topical herapy in the management of this condition, even when using systemic therapy.

This lecture will discuss the importance of topical therapy in the management of canine atopic dermatitis. We will review the changes detected in the skin of affected animals with a focus on the epidermal barrier. We will discuss the importance of topical herapy in the management of this condition, even when using systemic therapy.

07:30 PM PDT

1 RACE-Approved Credit Hour 
 

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

07:00 PM EDT

RACE# 27059-1119546

1.5 RACE-Approved Credit Hour 
 

The presentation will discuss the current rules and regulations of compounding for veterinary drugs. The speaker will begin with definitions and regulations that currently exist, then discuss what can go wrong with compounding drugs, and how that may impact patient care. The speaker will also discuss drug quality safety and GFI#256 and compounding for patients vs office use.

7:00 PM EDT

RACE# 27059-1196556

1 RACE-Approved Credit Hour 
 

Truly understand how adrenals work, the difference between Cushing's and Addison's disease, how to deal with emergency adrenal patients, and how these diseases are treated. This lecture is focused on veterinary technicians and will take into account the ERCC technician perspective.

7:00 PM EDT

RACE# 27059-1196578

1 RACE-Approved Credit Hour 
 

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

03:00 PM EDT

1 RACE-Approved Credit Hour 
 

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM EDT

1 RACE-Approved Credit Hour 
 

This lecture will discuss the importance of topical therapy in the management of canine and feline superficial pyoderma and other cutaneous bacterial infections. We will review the current state of antimicrobial resistance and why topical therapy should be considered often as a first line choice. We will review some of the topical therapeutics used in dermatologic cases.

This lecture will discuss the importance of topical therapy in the management of canine and feline superficial pyoderma and other cutaneous bacterial infections. We will review the current state of antimicrobial resistance and why topical therapy should be considered often as a first line choice. We will review some of the topical therapeutics used in dermatologic cases.

07:30 PM CDT

1 RACE-Approved Credit Hour 
 

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

7 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

The presenter will discuss different types of fluids available for use in veterinary patients with a short review of the types, the differences between the types, and a brief description on the use of crystalloids vs colloids. The presenter will also touch on appropriate fluid therapy types, techniques, and rates for resuscitation, rehydration, and preventing continuing fluid loss. The presentation will be from a criticalists perspective but will be geared to general practice.

07:00 PM EDT

RACE# 27059-1201360
1 RACE-Approved Credit Hour

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EDT

RACE# 27059-918761
1 RACE-Approved Credit Hour

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

7:00 PM EDT

RACE# 27059-918761
1 RACE-Approved Credit Hour

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

2:00 PM EDT

1 RACE-Approved Credit  

RACE# 27059-900255 

The presenter will discuss Keratoconjunctivitis Sicca (KCS). This will include case presentation, diagnosis and treatment. Presenter will discuss common presentations (including breed dispositions) and will briefly talk about diagnosis. The program will continue into a comparison of current therapies available to treat KCS including cyclosporine, tacrolimus, and others. Finally, the presenter will also touch on some additional modalities that can be used to manage the disease, including other ophthalmic preparations

7:00 PM EDT

RACE# 27059-1201902
1 RACE-Approved Credit Hour

All aspects of the complete equine pre-purchase exam will be discussed from initial work-up and diagnostics to liability and legal considerations. Case examples and in-depth videos will be presented to illustrate best practices for the lameness and general examination.

7:00 PM EDT

RACE# 27059-983180
1.5 RACE-Approved Credit Hours

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

07:00 PM EDT

RACE# 27059-1119546

1.5 RACE-Approved Credit Hour 
 

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

7:00 PM EDT

1 RACE-Approved Credit  

Canine otitis externa is one of the most frequently encountered conditions in small animal veterinary practice. This presentation explores the causes of canine otitis externa including the predisposing, secondary, primary and perpetuating factors, the importance of otic cytology, and the essential treatment modalities to help ensure clinical resolution. The development of a long-term maintenance cleaning and allergy management plan will also be discussed.

12:00 PM EDT

RACE# 27059-963682
1 RACE-Approved Credit Hour

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM EDT

1 RACE-Approved Credit Hour 
 

Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.

6:30 PM EDT

1 RACE-Approved Credit  

This presentation will discuss the state of regenerative therapies currently on the market. The presenter will then take a more in depth look at the role of Platelet Rich Plasma and stem cells and the various uses that they have in companion animal medicine. Finally, there will be a wrap up discussion on how regenerative therapies can be used in every companion animal general practice.

7:00 PM EDT

RACE# 27059-1218572
1 RACE-Approved Credit Hour

This program will go through the diagnostics of low back pain in dogs. The presenter will also discuss medical management and exercise techniques to help alleviate low back pain in dogs. These techniques and suggestions can improve the quality of life of the dog and the person who cares for the dog!

07:00 PM EDT

RACE# 27059-1201908
1 RACE-Approved Credit Hour

This lecture will discuss how the primary care doctor can be involved in diagnosing, staging, and treating canine lymphoma. We will discuss what staging should be performed in primary care, with an emphasis on immunophenotyping. We will concentrate on treatment options for the primary care doctor beyond prednisone, especially where Laverdia^®-CA1 fits in and why it must be on hand for all primary care practices

07:00 PM CDT

RACE# 27059-1203006

1 RACE-Approved Credit Hour

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

10:00 PM EDT

RACE# 27059-918761
1 RACE-Approved Credit Hour

Choosing the right type of fluid therapy for your patient can be difficult. This lecture discusses how fluids are selected, the differences between colloids and crystalloids, and the appropriate rate for the patient. Differences between the various crystalloids will be discussed. Technicians will gain a better understanding of fluid therapy.

07:00 PM EDT

RACE# 27059-1203008

1 RACE-Approved Credit Hour

This presentation breaks down the complex mechanisms of bisphosphonates as a drug class and their use in managing the clinical signs of navicular syndrome in horses. The second half of the presentation explores the clinical features of non-nitrogenous bisphosphonates including their efficacy and safety in real world field applications.

07:00 PM EDT

RACE# 27059-963582

1 RACE-Approved Credit Hour

This presentation will discuss the state of regenerative therapies currently on the market. The presenter will then take a more in depth look at the role of Platelet Rich Plasma and stem cells and the various uses that they have in companion animal medicine. Finally, there will be a wrap up discussion on how regenerative therapies can be used in every companion animal general practice.

7:00 PM EDT

RACE# 27059-1218572
1 RACE-Approved Credit Hour

With dermatologic conditions making up a large volume of the caseload in companion animal medicine and with antimicrobial resistance on the rise, topical therapies need to play a bigger role in dermatologic therapy. This presentation will discuss why topical therapies are helpful and how cytology helps guide topical product choice. The most common active ingredients in topical products for companion animals will be highlighted including their mechanism of action and suggested use. By having a complete understanding of active ingredients, veterinarians will be better equipped to make a topical product selection. Compliance strategies will be discussed to help ensure that what a veterinarian prescribes actually gets used.

07:00 PM EDT

RACE# 27059-906349

1 RACE-Approved Credit Hour

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

02:00 PM EDT

RACE# 27059-1119546

1.5 RACE-Approved Credit Hour 
 

This session will explore the effects of Fear, Anxiety and Stress (FAS) on routine diagnostics and provide Fear Free techniques to minimize and alleviate FAS during routine veterinary procedures

07:00 PM EDT

RACE# 27059-1203010

1 RACE-Approved Credit Hour 
 

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

02:00 PM EDT

RACE# 27059-918761
1 RACE-Approved Credit Hour

The presenter will discuss the ophthalmology examination and the role that veterinary technicians play. She will discuss common tests that should be performed on every ophthalmology examination and discuss the proper techniques for technicians to be able to perform those diagnostics. At the end of the presentation, the veterinary technician should be able to walk away with the knowledge to make every ophthalmology appointment a seamless experience for the veterinarian, the technician, and the pet!

07:00 PM EDT
 

RACE# 27059-1203464
1 RACE-Approved Credit Hour

This session will explore emotionally protective strategies for canine and feline patients experiencing high levels of fear, anxiety, and stress during veterinary procedures.

07:00 PM EDT
 

RACE# 27059-1203806
1 RACE-Approved Credit Hour

In this 1-hour virtual live lecture, Dr. Marks will start with a quick review of the prevalence of canine lymphoma and why early diagnosis is critical. The bulk of the lecture will focus on five critical areas the veterinary team can focus on for earlier diagnostics and education to pet parents. This includes at-risk breeds, questions to ask in the history, commonly missed clinical signs, subtle physical exam findings that dictate further diagnostics, and recommended workup options (including the spectrum of care.) The final sections of this presentation will discuss how to utilize resources for efficient and effective communication in your practice.

07:00 PM EDT
 

RACE# 27059-1174212
1 RACE-Approved Credit Hour

The presenter reviews equine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally, a meta-analysis of current research with regard to platelet rich plasma (PRP), autologous conditioned serum (ACS), autologous protein solutions (APS), and alpha 2 macroglobulin will be analyzed.

07:00 PM EDT
 

RACE# 27059-924918
1 RACE-Approved Credit Hour

This program will go through the pathophysiology of osteoarthritis and new insights into some of the key inflammatory mediators that are seen in the development of OA in the joint. The presenter will then discuss studies that have been performed on various supplements and nutraceuticals, including prescription diets that are formulated for joint health. Finally, the speaker will discuss the safety concerns of common supplements and what happens when animals are on too many supplements simultaneously.

07:00 PM EDT
 

RACE# 27059-1203814

1 RACE-Approved Credit Hour *PENDING*

This program will discuss the clinical manifestations of Cushings disease as viewed through the eyes of a dermatologist and an internal medicine specialist. The case-based presentation will highlight cases presented to both specialists and ultimately resulting in the diagnosis of Cushings. The presenters will also discuss diagnostics, treatment scenarios, and monitoring for the individual patients.

07:00 PM EDT
 

RACE# 27059-1203820

1.5 RACE-Approved Credit Hours

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

03:00 PM EDT

1 RACE-Approved Credit Hour 
 

This presentation will be given by a pharmacist who specializes in veterinary pharmacology. The Presenter will discuss the history of veterinary drug laws and identify FDA-approved veterinary medications. The presenter will go on to compare and contrast the different regulatory bodies in veterinary pharmaceuticals and how this differs from human pharmaceuticals. Finally, the presenter will focus on labeling requirements that would apply to most state pharmacy and veterinary laws. This presentation will fulfill drug law requirements for continuing education as set by state veterinary medical boards.

07:00 PM EDT
 

RACE# 27059-1206490

1 RACE-Approved Credit Hour

After nearly a decade of FDA-approval of non-nitrogenous bisphosphonates for use in horses, this presentation is meant to review our current understanding of these drugs and introduce newly available scientific data and research. Topics will include clinical efficacy data, pharmacokinetic studies, equine safety studies, and recently discovered effects in non-bone cells. To conclude, there will be an overview of some recent and relevant non-nitrogenous bisphosphonate clinical trials. Bisphosphates are a unique drug class with new discoveries regularly occurring in both human and veterinary medicine. This presentation will give attendees an opportunity to review previously known information and learn about recent developments in this drug class. This practical knowledge can be applied in the clinical setting when considering the use of bisphosphonate drugs in equine patients.

07:00 PM EST
 

RACE# 27059-933819

1 RACE-Approved Credit Hour

This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.

12 PM EST

1 RACE-Approved Credit  

RACE# 27059-900255 

This presentation will be given by a pharmacist who specializes in veterinary pharmacology. The presenter will discuss the record-keeping requirements for DEA-controlled drugs. The presenter will also discuss the various classifications of drugs and how some states classify them differently. Finally, the presenter will discuss the differences in logging and inventory management to meet the requirements of DEA logging CE for every state. This presentation will also fulfill the requirements of DEA logging CE in each state, including Florida.

07:00 PM EST
 

RACE# 27059-1206498

1 RACE-Approved Credit Hour

This presentation will discuss the diagnosis and management of both canine and feline chronic kidney disease (CKD). The presenter will discuss the chronic care of animals with CKD and common pitfalls seen in the management of these diseases. Presenter will also discuss pharmaceuticals and nutraceuticals that are often used to manage kidney health. Finally, the updated standards of practice will be given

7:00 PM EST

1 RACE-Approved Credit Hour 
RACE# 27059-1206504

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

12:00 PM EDT

1 RACE-Approved Credit Hour 
 

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

Veterinarians and Technicians are invited.

02:00 PM EST

RACE# 27059-918761
1 RACE-Approved Credit Hour

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

Veterinarians and Technicians are invited.

07:00 PM EDT

1 RACE-Approved Credit Hour 
 

This presentation provides a review of Canine Hypoadrenocorticism (Addison’s Disease); the topics include pathophysiology, signalment, clinical signs, diagnostics, treatment, and monitoring. Cases will be discussed to reinforce your diagnostic confidence.

Veterinarians and Technicians are invited.

07:00 PM EST

1 RACE-Approved Credit Hour 
 

The program will walk through the diagnostics and management of a dog with hyperadrenocorticism and diabetes mellitus. Preferred diagnostic testing, medical management, and alterations to the dosing regimen based on disease state will be addressed. Finally, the presenter will offer cases and examples of how to manage a dog with both comorbidities.

7:00 PM EST

RACE# 27059-1206516
1 RACE-Approved Credit Hour

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

3:00 PM EDT

1 RACE-Approved Credit Hour 
 

In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.

07:00 PM EST

RACE# 27059-918761
1 RACE-Approved Credit Hour

Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.

02:00 PM EST

RACE# 27059-1119546

1.5 RACE-Approved Credit Hour 
 

The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.

7:00 PM EDT

1 RACE-Approved Credit Hour 
 

Every one of us wants euthanasia procedures to go well. A dysthanasia is the opposite of a good death or a death where the quality of life is not considered. What is and isnt considered a good death is complicated. In this session, we review how pet owners and veterinarians define a good death and have a deeper understanding of what is and is not good in the owners eyes. We can then determine how best to address dysthanasias when they happen, to protect the mental health of loved ones and the veterinary team. Dysthanasias are upsetting, and how we handle them when they occur makes all the difference. There will be time to talk through challenging cases.

08:00 PM EST

RACE# 27059-1206526
1 RACE-Approved Credit Hour